Mediatum Co-Founder to Speak at Boston Biotech Conference
Christoph Boehringer Is Co-Founder of Global Life Sciences Executive Search Firm
(firmenpresse) - CAMBRIDGE, MA -- (Marketwire) -- 04/16/12 -- Mediatum, an executive search firm specializing in life sciences, today announced that co-founder Christoph Boehringer will be speaking at the Boston Biotech Conference, taking place April 17-18, 2012 at the Mandarin Oriental Hotel in Boston, MA. Boehringer will be speaking April 17 at 2:00 p.m. EDT, joining a panel of biotech, pharmaceutical, and executive search industry executives discussing "European and Asian Perspectives."
Boehringer is a frequent speaker who brings a wealth of knowledge and experience in the life sciences industry. In addition to his role as co-founder and managing director of Mediatum International, Boehringer is co-founder of CD-Venture, a private equity company, and member of the shareholder committee of Boehringer Ingelheim. Since co-founding Mediatum in Heidelberg, Germany in 2001, Boehringer has been instrumental in driving the company's expansion and opening offices in Vienna, Austria; Basel, Switzerland; London, UK; and, more recently, in Boston, MA.
For more information on the Boston Biotech Conference, go to
Mediatum is a globally-based executive search firm focusing exclusively on finding the best executives in the pharmaceutical, biotechnology, medical devices and diagnostics fields. Founded by Christoph Boehringer and Dirk Wilken in Heidelberg, Germany in 2001, Mediatum has since grown steadily, now operating branch offices in Basel, Vienna, London and Boston. For more information on Mediatum, visit
Contact:
Beth Bryant
BBWrites Communications
508-786-3013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 16.04.2012 - 14:30 Uhr
Sprache: Deutsch
News-ID 135322
Anzahl Zeichen: 0
contact information:
Town:
CAMBRIDGE, MA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 160 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Mediatum Co-Founder to Speak at Boston Biotech Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Mediatum (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
